+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Etravirine Market - Global Forecast 2026-2032- Product Image
Etravirine Market - Global Forecast 2026-2032- Product Image
Sale

Etravirine Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015385
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Etravirine Market is projected to reach USD 281.72 Million in 2026. It is expected to continue growing at a CAGR of 3.62%, reaching USD 342.04 Million by 2032.

Etravirine: Executive Summary and Market Context

Etravirine is a non-nucleoside reverse transcriptase inhibitor used in combination antiretroviral therapy for adults and selected pediatric patients with HIV-1 infection, particularly when resistance to other agents is a concern. Its clinical role is defined by treatment-experienced use, resistance-guided selection, combination therapy, and ongoing monitoring for adverse reactions and drug interactions. Assessment of this market therefore depends on treatment guidelines, HIV diagnosis and linkage to care, antiretroviral procurement systems, regulatory access, and the availability of resistance testing.

Treatment Evolution Is Reframing Etravirine’s Role

The antiretroviral treatment landscape has shifted toward highly potent, well-tolerated, once-daily regimens with high barriers to resistance. This evolution has narrowed the routine role of etravirine while preserving its relevance as a treatment-experienced option when prior regimens have failed or resistance patterns limit alternatives. Key structural changes include earlier treatment initiation, greater emphasis on viral suppression, broader use of regimen simplification, improved adherence support, and stronger integration of HIV services with primary and specialty care. Access decisions increasingly balance clinical need, resistance history, tolerability, interaction risk, and procurement efficiency.

Artificial Intelligence Can Improve Resistance-Guided Treatment Decisions

Artificial intelligence may support etravirine-related care by organizing resistance-test results, identifying potential drug-drug interactions, flagging adherence risks, and helping clinicians compare treatment histories with guideline-based options. It can also assist supply planning, pharmacovigilance signal detection, and patient-support workflows. These applications require validated datasets, transparent clinical logic, privacy safeguards, and human oversight. AI should augment infectious-disease expertise rather than independently determine therapy, because incomplete treatment histories, viral diversity, comorbidities, and interaction complexity can materially affect regimen selection.

Regional Access Depends on HIV Programs and Resistance Management

North America generally benefits from established HIV specialty care, laboratory capacity, and structured treatment guidelines, although formulary controls and affordability can influence access. Latin America’s priorities include sustained procurement, decentralized testing, and continuity of care across diverse health systems. Europe combines strong clinical infrastructure with country-specific reimbursement, health-technology assessment, and regulatory pathways. The Middle East requires attention to diagnosis, confidentiality, specialist availability, and uninterrupted medicine supply. Africa’s needs center on earlier diagnosis, differentiated service delivery, laboratory access, and resilient procurement. Asia-Pacific presents substantial variation, with advanced systems alongside settings where diagnosis, resistance testing, and long-term treatment continuity remain uneven.

Economic and Security Groupings Shape Procurement Priorities

ASEAN countries face varied regulatory environments and health-system capacity, making regional coordination and reliable procurement important. BRICS members encompass major public-health systems with different HIV burdens, domestic manufacturing capabilities, and access policies. The European Union benefits from coordinated scientific and regulatory structures while retaining national reimbursement decisions. G7 countries generally have mature HIV programs, advanced diagnostics, and greater capacity for evidence generation, but still address inequities among underserved populations. GCC states commonly combine strong healthcare investment with a focus on specialist access, screening, and confidential care. NATO members span diverse health systems, so preparedness, supply resilience, and continuity for mobile or displaced populations remain relevant.

Country Priorities Reflect Different Clinical and System Conditions

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States generally have specialist HIV services and established antiretroviral treatment frameworks, with national differences in reimbursement, resistance testing, and formulary placement. Brazil, Mexico, India, China, and Russia require country-specific consideration of public procurement, local regulatory requirements, treatment continuity, and laboratory access. Across all listed countries, etravirine’s positioning is most relevant where clinicians manage treatment-experienced patients, documented or suspected resistance, complex comorbidity, or interaction-sensitive regimens. National policy should also address stigma, retention in care, and equitable access to monitoring.

Prioritize Evidence, Interactions, and Continuity of Care

Industry leaders should maintain clear, guideline-aligned evidence on etravirine in treatment-experienced populations and communicate resistance-related use without overstating its role. They should strengthen interaction-management tools, educational support for clinicians and pharmacists, and patient information that promotes adherence and prompt reporting of adverse effects. Access strategies should align with public-health procurement requirements, local regulatory standards, and dependable distribution. Partnerships with laboratories and care providers can improve resistance testing and viral-load monitoring, while responsible data practices and validated analytics can support pharmacovigilance and service improvement.

Methodology: Evidence-Based Review of Clinical and Access Drivers

This executive summary uses a structured qualitative review framework centered on etravirine’s approved therapeutic role, treatment guidelines, resistance-management principles, HIV care delivery, regulatory and reimbursement considerations, and health-system access conditions. Regional, group, and country perspectives are synthesized from established public-health and clinical principles rather than unsupported numerical claims. The analysis excludes market estimates, market sizing, market shares, forecasts, and company-specific assessments. Interpretation should be updated as treatment guidelines, resistance patterns, regulatory decisions, and procurement policies change.

Etravirine Remains a Targeted Option in a Dynamic HIV Treatment System

Etravirine occupies a specialized position within modern HIV therapy: its importance is greatest when treatment history and resistance constrain regimen choice, rather than as a universal first-line option. Its continued clinical value will depend on appropriate patient selection, interaction-aware prescribing, reliable laboratory support, adherence and retention in care, and equitable medicine access. Leaders who connect evidence generation with practical treatment pathways and resilient health-system delivery will be best placed to support appropriate use across diverse regions and populations.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Etravirine Market, by Competition Type
7.1. Introduction
7.2. Branded
7.3. Generic
7.3.1. Approved Generic
7.3.2. Authorized Generic
8. Etravirine Market, by Packaging
8.1. Introduction
8.2. Blister Pack
8.3. Bottles
8.3.1. 30 Tablets
8.3.2. 60 Tablets
9. Etravirine Market, by End User
9.1. Introduction
9.2. Ambulatory Care
9.3. Clinics
9.3.1. Private Clinic
9.3.2. Public Clinic
9.4. Home Care
9.5. Hospitals
9.5.1. Private Hospital
9.5.2. Public Hospital
10. Etravirine Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.3.1. Mobile App
10.3.2. Website
10.4. Retail Pharmacy
11. Etravirine Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Etravirine Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Etravirine Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Apotex Pharmachem
15.2. Aurobindo Pharma Limited
15.3. Cipla Limited
15.4. Dr. Reddy’s Laboratories Limited
15.5. Hetero Drugs
15.6. Hetero Healthcare Limited
15.7. HRV Global Life Sciences
15.8. Johnson & Johnson
15.9. Lupin Limited
15.10. MSN Laboratories
15.11. Sandoz International GmbH
15.12. Sun Pharmaceutical Industries Limited
15.13. Teva Pharmaceutical Industries Limited
15.14. Viatris Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Etravirine Market, Years Considered for the Study
FIGURE 2. Global Etravirine Market, Research Design
FIGURE 3. Global Etravirine Market, Research Framework
FIGURE 4. Global Etravirine Market, Data Triangulation
FIGURE 5. Global Etravirine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Etravirine Market Size, by Competition Type, 2025 vs 2032 (%)
FIGURE 7. Global Etravirine Market Size, by Competition Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Etravirine Market Size, by Packaging, 2025 vs 2032 (%)
FIGURE 9. Global Etravirine Market Size, by Packaging, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Etravirine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Etravirine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Etravirine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Etravirine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Etravirine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Etravirine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Etravirine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Etravirine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Etravirine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Etravirine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Etravirine Market Segmentation & Coverage
TABLE 2. Global Etravirine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 4. Global Branded Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Branded Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Branded Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Approved Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Approved Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Approved Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Authorized Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Authorized Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Authorized Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 17. Global Blister Pack Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Blister Pack Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Blister Pack Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Bottles Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global 30 Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global 30 Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global 30 Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global 60 Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global 60 Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global 60 Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 30. Global Ambulatory Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Ambulatory Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Ambulatory Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Private Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Private Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Private Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Public Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Public Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Public Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 55. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Mobile App Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Mobile App Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Mobile App Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Website Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Website Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Website Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Etravirine Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Etravirine Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 81. North America Etravirine Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. North America Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 83. North America Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 84. North America Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 85. North America Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 86. North America Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. North America Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 88. North America Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 89. North America Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. North America Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 91. Latin America Etravirine Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Latin America Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 93. Latin America Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 94. Latin America Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 95. Latin America Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 96. Latin America Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Latin America Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 98. Latin America Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 99. Latin America Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Latin America Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 101. Europe Etravirine Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Europe Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 103. Europe Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 104. Europe Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 105. Europe Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 106. Europe Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Europe Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 108. Europe Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 109. Europe Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 110. Europe Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 111. Middle East Etravirine Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Middle East Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 113. Middle East Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 114. Middle East Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 115. Middle East Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 116. Middle East Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. Middle East Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 118. Middle East Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 119. Middle East Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. Middle East Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 121. Africa Etravirine Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Africa Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 123. Africa Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 124. Africa Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 125. Africa Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 126. Africa Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. Africa Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 128. Africa Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 129. Africa Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. Africa Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 131. Global Etravirine Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. ASEAN Etravirine Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. ASEAN Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 134. ASEAN Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 135. ASEAN Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 136. ASEAN Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 137. ASEAN Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. ASEAN Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 139. ASEAN Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 140. ASEAN Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. ASEAN Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 142. GCC Etravirine Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. GCC Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 144. GCC Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 145. GCC Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 146. GCC Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 147. GCC Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. GCC Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 149. GCC Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 150. GCC Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. GCC Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 152. European Union Etravirine Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. European Union Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 154. European Union Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 155. European Union Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 156. European Union Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 157. European Union Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. European Union Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 159. European Union Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 160. European Union Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. European Union Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 162. BRICS Etravirine Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. BRICS Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 164. BRICS Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 165. BRICS Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 166. BRICS Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 167. BRICS Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. BRICS Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 169. BRICS Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 170. BRICS Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. BRICS Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 172. G7 Etravirine Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. G7 Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 174. G7 Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 175. G7 Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 176. G7 Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 177. G7 Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. G7 Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 179. G7 Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 180. G7 Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. G7 Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 182. NATO Etravirine Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. NATO Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 184. NATO Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 185. NATO Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 186. NATO Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 187. NATO Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. NATO Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 189. NATO Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 190. NATO Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. NATO Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 192. Global Etravirine Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. United States Etravirine Market Size, 2017-2032 (USD Million)
TABLE 194. United States Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 195. United States Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 196. United States Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 197. United States Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 198. United States Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. United States Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 200. United States Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 201. United States Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. United States Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 203. Canada Etravirine Market Size, 2017-2032 (USD Million)
TABLE 204. Canada Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 205. Canada Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 206. Canada Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 207. Canada Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 208. Canada Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Canada Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 210. Canada Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 211. Canada Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. Canada Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 213. Mexico Etravirine Market Size, 2017-2032 (USD Million)
TABLE 214. Mexico Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 215. Mexico Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 216. Mexico Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 217. Mexico Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 218. Mexico Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Mexico Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 220. Mexico Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 221. Mexico Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 222. Mexico Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 223. Brazil Etravirine Market Size, 2017-2032 (USD Million)
TABLE 224. Brazil Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 225. Brazil Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 226. Brazil Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 227. Brazil Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 228. Brazil Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Brazil Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 230. Brazil Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 231. Brazil Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. Brazil Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 233. United Kingdom Etravirine Market Size, 2017-2032 (USD Million)
TABLE 234. United Kingdom Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 235. United Kingdom Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 236. United Kingdom Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 237. United Kingdom Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 238. United Kingdom Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. United Kingdom Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 240. United Kingdom Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 241. United Kingdom Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. United Kingdom Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 243. Germany Etravirine Market Size, 2017-2032 (USD Million)
TABLE 244. Germany Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 245. Germany Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 246. Germany Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 247. Germany Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 248. Germany Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Germany Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 250. Germany Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 251. Germany Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. Germany Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 253. France Etravirine Market Size, 2017-2032 (USD Million)
TABLE 254. France Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 255. France Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 256. France Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 257. France Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 258. France Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. France Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 260. France Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 261. France Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. France Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 263. Russia Etravirine Market Size, 2017-2032 (USD Million)
TABLE 264. Russia Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 265. Russia Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 266. Russia Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 267. Russia Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 268. Russia Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Russia Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 270. Russia Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 271. Russia Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 272. Russia Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 273. Italy Etravirine Market Size, 2017-2032 (USD Million)
TABLE 274. Italy Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 275. Italy Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 276. Italy Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 277. Italy Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 278. Italy Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Italy Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 280. Italy Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 281. Italy Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 282. Italy Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 283. Spain Etravirine Market Size, 2017-2032 (USD Million)
TABLE 284. Spain Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 285. Spain Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 286. Spain Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 287. Spain Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 288. Spain Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Spain Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 290. Spain Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 291. Spain Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 292. Spain Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 293. China Etravirine Market Size, 2017-2032 (USD Million)
TABLE 294. China Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 295. China Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 296. China Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 297. China Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 298. China Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. China Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 300. China Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 301. China Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 302. China Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 303. India Etravirine Market Size, 2017-2032 (USD Million)
TABLE 304. India Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 305. India Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 306. India Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 307. India Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 308. India Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. India Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 310. India Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 311. India Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 312. India Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 313. Japan Etravirine Market Size, 2017-2032 (USD Million)
TABLE 314. Japan Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 315. Japan Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 316. Japan Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 317. Japan Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 318. Japan Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 319. Japan Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 320. Japan Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 321. Japan Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 322. Japan Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 323. Australia Etravirine Market Size, 2017-2032 (USD Million)
TABLE 324. Australia Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 325. Australia Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 326. Australia Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 327. Australia Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 328. Australia Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 329. Australia Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 330. Australia Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 331. Australia Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 332. Australia Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 333. South Korea Etravirine Market Size, 2017-2032 (USD Million)
TABLE 334. South Korea Etravirine Market Size, by Competition Type, 2017-2032 (USD Million)
TABLE 335. South Korea Etravirine Market Size, by Generic, 2017-2032 (USD Million)
TABLE 336. South Korea Etravirine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 337. South Korea Etravirine Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 338. South Korea Etravirine Market Size, by End User, 2017-2032 (USD Million)
TABLE 339. South Korea Etravirine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 340. South Korea Etravirine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 341. South Korea Etravirine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 342. South Korea Etravirine Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 343. Global Etravirine Market Share, by Key Player, 2025
TABLE 344. Global Etravirine Market, Key Experts

Companies Mentioned

  • Apotex Pharmachem
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy’s Laboratories Limited
  • Hetero Drugs
  • Hetero Healthcare Limited
  • HRV Global Life Sciences
  • Johnson & Johnson
  • Lupin Limited
  • MSN Laboratories
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc.

Related Topics

Related Reports

Etravirine (CAS 269055-15-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Etravirine (CAS 269055-15-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Human Immunodeficiency Virus Therapeutics Market - Global Forecast 2026-2032 - Product Image

Human Immunodeficiency Virus Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
HIV Clinical Trials Market - Global Forecast 2026-2032 - Product Image

HIV Clinical Trials Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
HIV Drugs Market Report 2026 - Product Image

HIV Drugs Market Report 2026

  • Report
  • 250 Pages
  • Global
From
AIDS Treatment Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035) - Product Image

AIDS Treatment Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)

  • Report
  • 400 Pages
  • Global
From

About the Market

Etravirine is an antiretroviral drug used to treat HIV/AIDS. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that works by blocking the action of the HIV-1 reverse transcriptase enzyme, which is responsible for the replication of the virus. Etravirine is used in combination with other antiretroviral drugs to treat HIV-1 infection in adults and adolescents over the age of 12. It is also used to treat HIV-1 infection in adults and adolescents over the age of 12 who have already been treated with other antiretroviral drugs. Etravirine is available in tablet form and is taken orally. It is usually taken twice daily with food. Common side effects of etravirine include nausea, headache, and dizziness. More serious side effects may include liver problems, changes in body fat, and changes in the immune system. Etravirine is marketed by several pharmaceutical companies, including Janssen Pharmaceuticals, Merck & Co., and Tibotec Pharmaceuticals. It is also available in generic form from several generic drug manufacturers. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.